Brain imaging study for sickle cell disease in children
Part of Blood & lymphatic, Brain & nervous system, Injuries & trauma clinical trials.
This study uses two brain scans—transcranial Doppler (TCD) and magnetic resonance angiography (MRA)—to monitor blood flow and arteries in children with sickle cell anemia. It aims to help guide future treatment and prevent strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 2 to 18 years old
- Diagnosed with sickle cell anemia (HbSS type)
- Parent or guardian agrees to sign consent form and child agrees to participate
- Able to come to follow-up visits for at least 2 years
- Not currently needing regular blood transfusions or having a reason to avoid them
- Not taking any other treatments that could interfere with the study results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how well blood flows through brain arteries in children with sickle cell disease using a noninvasive ultrasound test. It may help doctors better understand stroke risk and how treatments like hydroxyurea or recent care affect blood flow.
This study uses MRI scans to understand how the brain and blood vessels are affected in children with sickle cell disease, including before and after certain treatments. It also includes healthy children for comparison and may help improve future monitoring and care.
This study uses a special light-based device and MRI to measure how blood vessels in the brain respond to changes. It may help researchers better understand blood flow in people with and without sickle cell disease.
This study uses an MRI scan to measure how your brain uses oxygen. It includes healthy participants and people with sickle cell disease or who previously needed ECMO, which may help researchers understand brain oxygen problems and how to monitor them.
This study looks at how major organs like the brain, kidneys, heart, and liver are affected in adults with sickle cell disease, whether they've had a bone marrow transplant or gene therapy, or are continuing regular treatment. You'll get detailed tests that can help doctors understand the disease better, which may lead to improved care.
This study tests whether shining a special light on the head (called transcranial photobiomodulation) can help children with sickle cell disease. It aims to improve blood flow and reduce brain damage.
Hear when a new Blood Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.